Beauty Health (NASDAQ:SKIN) Rating Lowered to “Strong Sell” at Zacks Research

Beauty Health (NASDAQ:SKIN) was downgraded by equities researchers at Zacks Research from a “hold” rating to a “strong sell” rating in a research report issued to clients and investors on Wednesday,Zacks.com reports.

Other analysts have also issued research reports about the company. Weiss Ratings reiterated a “sell (d-)” rating on shares of Beauty Health in a research note on Friday, October 31st. Jefferies Financial Group restated a “hold” rating and issued a $1.60 price target on shares of Beauty Health in a report on Wednesday, January 14th. Wall Street Zen lowered shares of Beauty Health from a “buy” rating to a “hold” rating in a report on Saturday, November 8th. Finally, TD Cowen boosted their price objective on shares of Beauty Health from $1.50 to $1.65 and gave the company a “hold” rating in a research report on Wednesday. One equities research analyst has rated the stock with a Buy rating, four have issued a Hold rating and two have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Reduce” and an average price target of $2.40.

Beauty Health Price Performance

Beauty Health stock opened at $1.56 on Wednesday. Beauty Health has a 12-month low of $0.78 and a 12-month high of $2.69. The company has a current ratio of 4.98, a quick ratio of 4.07 and a debt-to-equity ratio of 5.53. The firm has a 50-day moving average price of $1.45 and a 200-day moving average price of $1.70. The firm has a market capitalization of $198.90 million, a PE ratio of -7.09 and a beta of 1.16.

Beauty Health (NASDAQ:SKIN) last posted its quarterly earnings data on Thursday, November 6th. The company reported ($0.09) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.08) by ($0.01). Beauty Health had a negative return on equity of 19.70% and a negative net margin of 3.87%.The firm had revenue of $70.66 million during the quarter, compared to analysts’ expectations of $68.33 million. As a group, equities research analysts forecast that Beauty Health will post -0.25 EPS for the current year.

Institutional Trading of Beauty Health

A number of hedge funds have recently bought and sold shares of the stock. Public Employees Retirement System of Ohio bought a new position in shares of Beauty Health in the 3rd quarter worth $26,000. Franklin Resources Inc. purchased a new position in Beauty Health in the third quarter valued at about $31,000. SG Americas Securities LLC raised its holdings in Beauty Health by 111.9% in the fourth quarter. SG Americas Securities LLC now owns 24,670 shares of the company’s stock worth $34,000 after purchasing an additional 13,026 shares in the last quarter. Zacks Investment Management purchased a new stake in shares of Beauty Health during the third quarter valued at about $35,000. Finally, Ameriprise Financial Inc. bought a new stake in shares of Beauty Health in the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 93.26% of the company’s stock.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.